A review of the inherited ataxias: Recent advances in genetic, clinical and neuropathologic aspects

Parkinsonism and Related Disorders

Volumn 4, Issue 4, 1998, Pages 161-169

  Furtado, Sarah ^a   Das, Shyamal ^b   Suchowersky, Oksana ^a  

^a UNIVERSITY OF CALGARY   (Canada)

^b BANGUR INSTITUTE OF NEUROLOGY   (India)

Author keywords

Ataxia; Cerebellum; Genetic

Indexed keywords

ARTICLE; ATAXIA; ATAXIA TELANGIECTASIA; AUTOSOMAL DOMINANT INHERITANCE; AUTOSOMAL RECESSIVE INHERITANCE; CEREBELLAR ATAXIA; CLINICAL FEATURE; DENTATORUBROPALLIDOLUYSIAN ATROPHY; DISEASE CLASSIFICATION; FRIEDREICH ATAXIA; HUMAN; NEUROPATHOLOGY; POINT MUTATION; PRIORITY JOURNAL; TRINUCLEOTIDE REPEAT;

EID: 0032432411     PISSN: 13538020     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1353-8020(98)00030-3     Document Type: Review

References (75)

1. Harding AE. Classification of the hereditary ataxias and paraplegias, Lancet (1983) 1151-1154.
2. Harding AE. Clinical features and classification of inherited ataxias. In: Harding AE, Deufel T, editors. Adv. Neurol. Vol. 61, 1993.
3. Silveira I., Lopes-Cendes I., Kish S. et al. Frequency of spinocerebellar ataxia type 1. Neurology. 46:1996;214-218.
4. Geschwind D.H., Perlman D., Figueroa C.P., et al. The prevalence and wide clinical spectrum of the spinocerebellar ataxia type 2 trinucleotide repeat in patients with autosomal dominant cerebellar ataxia. Am J Hum Genet. 60:1997;842-850.
5. Durr A., Smadja D., Cancel G., et al. Autosomal dominant cerebellar ataxia type I in Martinique (French West Indies). Clinical and neuropathological analysis of 53 patients from three unrelated SCA2 families. Brain. 118:1995;1573-1581.
6. Goldfarb L.C., Vasconcelos O., Platonov F.A., et al. Unstable triplet repeat and phenotypic variability of spinocerebellar ataxia type 1. Ann Neurol. 39:1996;500-506.
7. Burk K., Abele M., Fetter M., et al. Autosomal dominant cerebellar ataxia type I. Clinical features and MRI in families with SCA1, SCA2 and SCA3. Brain. 119:1996;1497-1505.
8. Lopes-Cendes I., Maciel P., Kish S., et al. Somatic mosaicism in the central nervous system in spinocerebellar ataxia type 1 and Machado-Joseph disease. Ann. Neurol. 40:1996;99-206.
9. Gilman S., Sima A.A.F., Junck L., et al. Spinocerebellar ataxia type 1 with multiple system degeneration and glial cytoplasmic inclusions. Ann Neurol. 39:1996;241-255.
10. Giunti P., Sabbadini G., Sweeney M.G., et al. The role of the SCA2 trinucleotide repeat expansion in 89 autosomal The role of the SCA2 trinucleotide repeat expansion in 89 autosomal dominant cerebellar ataxia families. Frequency, clinical and genetic correlates. Brain. 121:1998;459-467.
11. Lorenzetti D., Bohlega S., Zoghbi H.Y. The expansion of the CAG repeat in ataxin-2 is a frequent cause of autosomal dominant spinocerebellar ataxia. Neurology. 49:1997;1009-1013.
12. Abele M., Burk K., Andres F., et al. Autosomal dominant cerebellar ataxia type I. Nerve conduction and evoked potential studies in families with SCA1, SCA2 and SCA3. Brain. 120:1997;2141-2148.
13. Matilla T., McCall A., Subramony S.H., Zoghbi H.Y. Molecular and clinical correlations in spinocerebellar ataxia type 3 and Machado-Joseph disease. Ann Neurol. 38:1995;68-72.
14. Giunti P., Sweeney M.G., Harding A.E. Detection of the Machado-Joseph disease/spinocerebellar ataxia three trinucleotide repeat expansion in families with autosomal dominant motor disorders, including the Drew family of Walworth. Brain. 119:1995;1077-1085.
15. Kawaguchi Y., Okamoto T., Taniwaki M., et al. CAG expansion in a novel gene for Machado-Joseph disease at chromosome 14q32.1. Nat Genet. 8:1994;221-227.
16. Sequeiros J., Coutinho P. Epidemiology and clinical aspects of Machado-Joseph disease. Adv Neurol. 61:1993;139-153.
17. Junck L., Fink J.K. Machado-Joseph disease and SCA3: the genotype meets the phenotype. Neurology. 46:1996;4-8.
18. Coutinho P., Andrade C. Autosomal dominant system degeneration in Portuguese families of the Azores Islands: a new genetic disorder involving cerebellar, pyramidal, extrapyramidal and spinal cord motor functions. Neurology. 28:1978;703-709.
19. Durr A., Stevanin G., Cancel G., et al. Spinocerebellar ataxia 3 and Machado-Joseph disease: clinical, molecular and neuropathological features. Ann Neurol. 39:1997;490-499.
20. Hashida H., Goto J., Kurisaki H., Mizusawa H., Kanazawa I. Brain regional differences in the expansion of a CAG repeat in the spinocerebellar ataxias: dentatorubral-pallidoluysian atrophy, Machado-Joseph disease and spinocerebellar ataxia type 1. Ann Neurol. 41:1997;505-511.
21. Onodera O., Idezuka J., Igarashi, et al. Progressive atrophy of cerebellum and brainstem as a function of age and the size of the expanded CAG repeats in the MJD1 gene in Machado-Joseph disease. Ann Neurol. 43:1998;288-296.
22. Flanigan K., Gardner K., Alderson K., et al. Autosomal dominant spinocerebellar ataxia with sensory axonal neuropathy (SCA 4): clinical description and genetic localization to chromosome 16q22.1. Am J Hum Genet. 59:1996;392-399.
23. Ranum L.P.W., Schut L.J., Lundgren J.K. Spinocerebellar ataxia type 5 in a family descended from the grandparents of President Lincoln maps to chromosome 11. Nat Genet. 8:1994;280-284.
24. Matsumura R., Futamura N., Fujimoto Y., et al. Spinocerebellar ataxia type 6. Molecular and clinical features of 35 Japanese patients including one homozygous for the CAG repeat expansion. Neurology. 49:1997;1238-1242.
25. Ikeuchi T., Takano H., Koidi R., et al. Spinocerebellar ataxia type 6: CAG repeat expansion in alpha-1-a voltage-dependent calcium channel gene and clinical variations in Japanese population. Ann Neurol. 42:1997;879-884.
26. Stevanin G., Durr A., David G., et al. Clinical and molecular features of spinocerebellar ataxi type 6. Neurology. 49:1997;1243-1246.
27. Schols L., Kruger R., Amoiridis G., et al. Spinocerebellar ataxia type 6: genotype and phenotype in German kindreds. J Neurol Neurosurg Psych. 64:1998;67-73.
28. Geschwind D.H., Perlman S., Figueroa K.P., et al. Spinocerebellar ataxia type 6. Frequency of the mutation and genotype-phenotype correlations. Neurology. 49:1997;1247-1251.
29. Zhuchenko O., Bailey J., Bonnen P., et al. Autosomal dominant cerebellar ataxia (SCA6) associated with small polyglutamine expansions in the alpha-1-a-voltage dependent calcium channel. Nat Genet. 15:1997;62-69.
30. Gomez C.M., Thompson R.M., Gammach J.T., et al. SCA6: gaze-evoked vertical nystagmus. Purkinje cell degeneration and variabe age of onset. Ann Neurol. 42:1997;933-950.
31. David G., Abbas N., Stevanin G., et al. Cloning of the SCA7 gene reveals a highly unstable CAG repeat expansion. Nat Genet. 17:1997;65-70.
32. Benomar A., Krols L., Stevanin G., et al. The gene for autosomal dominant cerebellar ataxia with pigmentary macular dystrophy maps to chromosome 3p12-p21.1. Nat Genet. 10:1995;84-88.
33. Gouw L.G., Kaplan C.D., Haines J.H., et al. Reginal degeneration characterizes a spinocerebellar ataxia mapping to chromosome 3p. Nat Genet. 10:1995;89-93.
34. Orr H.T., Chung M., Banfi. Expansion of an unstable trinucleotide CAG repeat in spinocerebellar ataxia type 1. Nat. Genet. 4:1993;221-226.
35. Klockgether T., Ludtke R., Kramer B., et al. The natural history of degenerative ataxia: a retrospective study in 466 patients. Brain. 121:1998;589-600.
36. Burright E.N., Clark H.B., Servadio A., et al. SCA1 transgenic mice: a model of neurodegeneration caused by an expanded CAG trinucleotide repeat. Cell. 82:1995;937-948.
37. Skinner P.J., Koshy B.T., Cummings C.J., et al. Ataxin-1 with an expanded glutamine tract alters nuclear matrix-associated structures. Nature. 30:1997;971-978.
38. Pulst S.-M., Nechiporuk A., Nechiporuk T., et al. Moderate expansion of a normally biallelic trinucleotide repeat in spinocerebellar ataxia type 2. Nat Genet. 14:1996;269-276.
39. Imbert G., Sandou F., Yvert G., et al. Cloning of the gene for spinocerebellar ataxia type 2 reveals a locus with high sensitivity to expanded CAG/glutamine repeats. Nat Genet. 14:1996;285-291.
40. Paulson H.L., Perez M.K., Trottier Y., et al. Intranuclear inclusions of expanded polyglutamine protein in spinocerebellar ataxia type 3. Neuron. 19:1997;333-344.
41. Ikeda Y, Yamaguchi M, Sugai S, et al. Expanded polyglutamine in the Machado-Joseph disease protein induces cell death in vitro and in vivo. Nat Genet 13:196-202.
42. Greenberg D.A. Calcium channels in neurological disease. Ann Neurol. 42:1997;275-282.
43. Trottier Y., Lutz Y., Stevanin G., et al. Polyglutamine expansion as a pathological epitope in Huntington's disease and four dominant cerebellar ataxias. Nature. 378:1995;403-405.
44. DiBenedetta A.J., Pittman R.N. Death in the balance. Pers Dev Neurobiol. 3:1996;111-120.
45. Perutz M.F., Johnson T., Suzuki M., Finch J.T. Proc Nat Acad Sci. 91:1994;5355-5358.
46. Nagafuchi S., Yanagisawa H., Sato K., et al. Dentatorubral and pallidoluysian atrophy expansion of an unstable CAG trinucleotide repeat on chromosome 12p. Nat Genet. 6:1994;14-18.
47. Burke J.R., Wingfield M.S., Lewis K.E., et al. The haw river syndrome: dentatorubropallidoluysian atrophy in an African-American family. Nat Genet. 7:1994;521-524.
48. Browne D.L., Gancher S.T., Nutt J.G., et al. Episodic ataxia/myokymia syndrome is associated with point mutations in the human potassium channel gene, KCNA-1. Nat Genet. 8:1994;136-140.
49. Baloh R.W., Yue Q., Furman J.M., Nelson S.F. Familial episodic ataxia: clinical heterogeneity in four families linked to chromosome 19p. Ann Neurol. 41:1997;8-16.
50. Calandriello L., Veneziano L., Francia A., et al. Acetazolamide-responsive episodic ataxia in an Italian family refines gene mapping on chromosome 19p13. Brain. 120:1997;805-812.
51. Ophoff R.A., Terwindt G.M., Vergouwe M.N., et al. Familial hemiplegic migraine and episodic ataxia type-2 are caused by mutations in the Ca2+ channel gene CACNL1A4. Cell. 87:1996;543-552.
52. Campuzano V., Montermini L., Molto D., et al. Friedreich's ataxia: autosomal recessive disease caused by intronic GAA triplet repeat expansion. Science. 271:1996;1423-1427.
53. Babcock M., de Silva D., Oaks R., et al. Regulation of mitochondrial iron accumulation by Yfh11p, a putative homolog of frataxin. Science. 276:1997;1709-1712.
54. Priller J., Scherzer C.R., Faber P.W., et al. Frataxin gene of Friedreich's ataxia in targeted to mitochondria. Ann Neurol. 42:1997;265-269.
55. Wilson R.B., Roof D.M. Respiratory deficiency due to loss of mitochondrial DNA in yeast lacking the frataxin homologue. Nat Genet. 16:1997;352-357.
56. Wilson R.B., Lynch D.R., Fischbeck K.H. Normal serum iron and ferritin concentrations in patients with Friedreich's ataxia. Ann Neurol. 44:1998;132-134.
57. De Michele G., Filla A., Cavalcanti F., et al. Late onset Friedreich's disease: clinical features and mapping of mutation to the FRDA locus. J Neurol Neurosurg Psych. 57:1994;977-979.
58. Montermini L., Richter A., Morgan K., et al. Phenotypic variability in Friedreich ataxia: role of the associated GAA triplet repat expansion. Ann Neurol. 41:1997;675-682.
59. Hanna M.G., Davis M.B., Sweeney M.G., et al. Generalized chorea in two patients harboring the Friedreich's ataxia gene trinucleotide repeat expansion. Mov Dis. 13:1998;339-340.
60. Durr A., Cossee M., Agid Y., et al. Clinical and genetic abnormalities in patients with Friedreich's ataxia. Nejm. 335:1996;1169-1175.
61. Schols L., Amoiridis G., Przuntek H., et al. Friedreich's ataxia. Revision of the phenotype according to molecular genetics. Brain. 120:1997;2131-2140.
62. Isnard R., Kalotka H., Durr A., et al. Correlation between left ventricular hypertrophy and GAA trinucleotide repeat length in Friedreich's ataxia. Circulation. 98:1997;2247-2249.
63. Filla A., De Michele G.D., Cavalcanti F., et al. The relationship between trinucleotide (GAA) repeat length and clinical features in Friedreich ataxia. Am J Hum Genet. 59:1996;554-560.
64. Yokota T., Shiojiri T., Gotoda T., et al. Friedreich-like ataxia with retinitis pigmentosa caused by the his Gln mutation of the alpha-tocopherol transfer protein gene. Ann Neurol. 41:1997;826-832.
65. Larnaout A., Belal S., Zouari M., et al. Friedreich's ataxia with isolated viatmin E deficiency: a neuropathological study of a Tunisian patient. Acta Neuropath. 93:1997;633-637.
66. Woods C.G., Taylor A.M.R. Ataxia telangiectasia in the British Isles: the clinical and laboratory features of 70 affected individuals. Q J Med. 298:1992;169-179.
67. Lavin M., Shiloh Y. Ataxia-telangiectasia: a multifaceted genetic disorder associated with defective signal transduction. Curr Op Immunol. 8:1996;459-464.
68. Shiloh Y. Ataxia-telangiectasia and the Nijmegen breakage syndrome: related disorders but genes apart. Ann Rev Genet. 31:1997;635-662.
69. Savitsky K., Bar-Shira A., Gilad S., et al. A single ataxia telangiectasia gene with a product similar to PI-3 kinase. Science. 268:1995;1749-1753.
70. Gatti R.A., Berkel I., Boder E., et al. Localization of an ataxia-telangiectasa gene to chromosome 11q22-23. Nat Genet. 4:1993;295-299.
71. Furtado S., Suchowersky O. Huntington's disease: recent advances in diagnosis and management. Can J Neurol Sci. 22:1995;5-12.
72. Fox S., Bloch M., Fahy M., Hayden M.R. Predictive testing for Huntington's Disease, I. Description of a pilot project in British Columbia. Am. J. Med. Genet. 32:1989;211-216.
73. Huggins M., Bloch M., Wiggins S., et al. Predictive testing of Huntington's disease in Canada: adverse effects and unexpected results in those receiving a decreased risk. Am J Med Genet. 42:1992;508-515.
74. Wiggins S., Whyte P., Huggins M., et al. The psychological consequences of predictive testing for Huntington's Disease. N Engl J Med. 327:1992;1401-1405.
75. World Federation of Neurology Research Group on Huntington's Disease. Ethical issues policy statement on Huntington's disease: molecular genetics and predictive testing. J Med Genet. 27:1990;34-38.